MRPL13 and breast carcinoma: Another study found that MRPL13 knockdown inhibits invasion in both non-invasive (MCF-7, T47D) and invasive (MDA-MB-231) breast cancer cells [53, 55], partly through diminished EMT processes [55], which suggests that MRPL13 expression may contribute to the acquisition of metastatic traits in breast cancer.